Detalles de la búsqueda
1.
Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial.
BJU Int
; 125(2): 215-225, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31614071
2.
A clinical review on extreme hypofractionated stereotactic body radiation therapy for localized prostate cancer using nonrobotic linear accelerators.
Cancer Invest
; 32(5): 191-6, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24654695
3.
A Phase II Study of Stereotactic Body Radiation Therapy for Low-Intermediate-High-Risk Prostate Cancer Using Helical Tomotherapy: Dose-Volumetric Parameters Predicting Early Toxicity.
Front Oncol
; 4: 336, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25505734
Resultados
1 -
3
de 3
1
Próxima >
>>